← SynDRA
JNJ-37822681
SynDRA canonical compound SYN0037994 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- KCNQ3 ACTIVATOR
- dopamine receptor antagonist
- DRD2 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- UNII-GJB2URS7NJ
- GJB2URS7NJ
- CHEMBL3234237
- SCHEMBL1022639
- MolPort-039-267-898
- BDBM50003063
- ZINC34951380
- DB12579
- 3-Pyridazinamine, N-(1-((3,4-difluorophenyl)methyl)-4-piperidinyl)-6-(trifluoromethyl)-
- NCGC00386644-01
- Z1558691527
- RefChem:150539
- JNJ37822681dihydrochloride
- UVUYWJWYRLJHEN-UHFFFAOYSA-N
- orb1305045
- SCHEMBL29634868
- SCHEMBL30349143
- GTPL14136
- KMB77674
- EBC-07564
- AKOS040748628
- JNJ37822681
- TS-08555
- CS-0034121
- NS00072136
- T27677
- EN300-1700043
- BRD-K31802667-001-01-9
- C17H19Cl2F5N4
- JNJ-37822681 (dihydrochloride)
- JNJ 37822681 dihydrochloride
- CS-0099689
- EN300-1700042
- Y3XCP46PA8
- UNII-Y3XCP46PA8
- MS-28021
- E98972
- orb1309525
Look up JNJ-37822681 in the interactive SynDRA portal →